ReviewCurrent treatment options in oncology2023

Which Second-Line Tyrosine Kinase Inhibitor(s) for Chronic Myeloid Leukemia?

Robert D Schwab et al.PubMed ↗Publisher ↗

No numbers read from the abstract.